• Home
  • Contact Us
  • Try it!
  • Graphs
  • Publications
  • Blog

Follow us

Recent Posts

  • NEWROAD final meeting April 28, 2026
  • Biovista Vizit New Corpus: ClinicalTrials.gov September 16, 2025
  • Biovista Vizit New Corpus: MATISSE (a SoftMining algorithm) May 13, 2025
  • Biovista Vizit New Corpus: HPO March 4, 2025
  • Biovista Vizit January 2025 Release – AOP Features January 30, 2025

Biovista Vizit

Biovista Vizit

  • Try it!
  • Graphs
  • Publications
  • Blog

Nervous System Disorders

Epilepsy, Autism and Muscular Dystrophy

August 27, 2018Autism, Cognition, Epilepsy, Muscular Dystrophy, Nervous System Disorders, Other, Vizit Graphs
Epilepsy, Autism and Muscular Dystrophy

Start exploring how Genes related to Cognition affect Epilepsy, Autism or Muscular Dystrophy with Biovista Vizit. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Parkinson’s disease and Autophagy

August 24, 2018Autophagy, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Autophagy

Find genes related to Parkinson’s disease and Autophagy, with Biovista Vizit. Explore the live graph.

Biomarkers for ALS

August 24, 2018Amyotrophic Lateral Sclerosis, Biomarkers, Nervous System Disorders, Vizit Graphs
Biomarkers for ALS

Find Biomarkers related to Amyotrophic lateral sclerosis with Biovista Vizit. Explore the live graph.

Repurposing Pirlindole for Multiple Sclerosis

August 24, 2018Featured, Multiple Sclerosis, Nervous System Disorders, Vizit Graphs
Repurposing Pirlindole for Multiple Sclerosis

Mechanism of action of Pirlindole in Multiple Sclerosis. Explore the live graph.

123
THY-1 ANTIGENS VERO CELLS TAU TGF-BETA TRANSPORT VITAMIN D THROMBOCYTOPENIA TUMOR VIRUS DISEASES TROGLITAZONE TUMOR PROGRESSION TRASTUZUMAB VIRAL RELEASE FROM HOST CELL Uberon X-RAY COMPUTED TOMOGRAPHY TYPE 2 DIABETES VGF PROTEIN TROPISM VEGFA TP53 THROMBOSIS VASODILATION THROMBIN TMPRSS2 VEGF TH17 CELLS UCHL1 PROTEIN TREPONEMA DENTICOLA TIMELESS VEINS TARGET LESION IDENTIFICATION UBIQUITINATION TAUOPATHIES ULCERATIVE COLITIS TRACHEA TUMOR GROWTH TISSUE DEVELOPMENT VASOCONSTRICTION THORAX TRANSLATION TECFIDERA WOUND HEALING VASCULAR

© 2026 Biovista Vizit All Rights Reserved.

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}